$ERO

Ero Copper Corp. (NYSE:ERO) Receives $31.50 Average Price Target from Analysts

MarketBeat reports that 17 analysts cover Ero Copper (NYSE:ERO), assigning an average “Moderate Buy” rating and a $31.50 average 12-month price target. Ten rate it “hold,” five “buy,” and two “strong buy.” Recent actions include Scotiabank restating “outperform” and Goldman cutting to “neutral” with a $31 target. ERO reported May 4 EPS of $0.69 vs $0.56 consensus on $263.2M revenue.

Original reporting
Published Jun 20, 2026, 9:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 20, 2026, 10:16 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ero Copper Corp. (NYSE:ERO) Receives $31.50 Average Price Target from Analysts — source image
Decision brief

The 30-second read

$ERONeutralLow
01

Why it matters

This is a sentiment/valuation update (consensus rating and average 12-month target) rather than a new fundamental disclosure. The most actionable element is the stated $31.50 average target alongside recent rating/PT revisions by named banks.

02

Market read

Traders may use the $31.50 average target and mixed recent bank actions to gauge near-term sentiment, but there is no new earnings/guidance/operational catalyst in the text.

03

What to watch

The article doesn’t provide updated guidance, mine plan changes, or new contract/financing details; traders should weigh whether the $31.50 target is meaningfully above current price versus the lack of fresh fundamentals.

Relevance 4/10Novelty 4/10Timing: pre-market/early session context for analyst-consensus positioning

Background

ERO is a copper concentrate producer with operations tied to the Vale do Curaçá complex in Brazil; the article frames current sentiment via analyst ratings and references a prior earnings release date.

Company-level read

Ticker impact

$ERONeutralMedium confidence
Context

Article cites ERO’s analyst consensus “Moderate Buy” plus a specific average 12-month price target of $31.50 and recent rating/PT changes.

Expected impact

Limited near-term impact; any move is likely sentiment/positioning around the $31.50 target rather than a fresh fundamental catalyst.

Evidence & confidence

The only concrete, decision-relevant items are analyst rating/PT updates and the stated average target; the earnings beat is referenced as having occurred on May 4, not newly disclosed here.

Market effects

Analyst sentiment on a copper producer can marginally influence broader base-metals equity risk appetite, but the article provides no new commodity or company-specific production guidance.

No distinct regional catalyst beyond general North American mining-equity sentiment.

No new global copper demand/supply or policy development is disclosed.

Counterpoint

Analyst targets may lag fundamentals; the Goldman downgrade to neutral and PT cut to $31 from $33 hints that upside may be capped without new production/cost or copper-price catalysts.

Key entities

  • Ero Copper Corp.

    Subject of the article; analyst consensus and average 12-month price target are provided, plus references to recent rating/PT changes.

  • Goldman Sachs Group

    Cut ERO from buy to neutral and reduced price target from $33.00 to $31.00 (as cited in the article).

  • Scotiabank

    Restated an “outperform” rating on ERO (as cited in the article).

Related articles

$EROMedAI 8/10

Ero Copper (ERO) Q2 2026 Earnings Call Transcript

Ero Copper (ERO) reported Q2 2026 revenue of $284.3 million, up 8% sequentially, and adjusted EBITDA of $144 million, up from $125.2 million, helped by higher copper prices and gold volumes. Cash flow from operations was $137.9 million. Net debt fell to $452.7 million. Guidance: copper 67,500-77,500 tonnes; mined gold 40,000-50,000 oz.

$EROMed

Ero Copper Q2 Earnings Call Highlights

Ero Copper (NYSE: ERO) reported Q2 call highlights. At Tucumã, copper output rose 6% sequentially to 8,964 tonnes, with throughput up 27% to ~250,000 to 260,000 tonnes/month. At Xavantina, gold production rose 170% to over 20,000 oz. Q2 revenue was $284.3m; net debt fell $38m to ~$453m. 2026 mined-gold C1 guidance is $1,100-$1,350/oz and AISC $2,200-$2,700/oz.

$MFCMed

Tuesday’s analyst upgrades and downgrades

TD Cowen analyst Mario Mendonca raised targets for Canadian insurers, citing strong equity markets and expected Q2/26 earnings growth. Great-West Lifeco (GWO) target to $98, Manulife (MFC) to $65, Sun Life (SLF) to $121, IA Financial (IAG) to $214. Stifel lifted copper price forecasts to $6.04/lb in 2026 and raised targets for CS, ERO, FM, FCX, HBM. National Bank Financial upgraded Tidewater Midstream (TWM) to Outperform.

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

$EXCMed

Why Exelon's CFO is stepping into a new strategy role

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.